Not Yet Recruiting
Trientine Tetrahydrochloride Administered Once a Day for the First Line Treatment of Wilson's Disease Patients.
NCT07465718
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Brain Diseases, Metabolic, +16 more
- Locations
-
- University of Colorado Anschutz School of Medicine Denver, Colorado, United States
- Yale University School of Medicine New Haven, Connecticut, United States
- University of Michigan Medical Centre Ann Arbor, Michigan, United States